Bookmark and Share
BioAssay: AID 588434

Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_Activity_Set2

Keywords: Glycogen synthase kinase-3 alpha (GSK3alpha), kinase, acute myeloblastic leukemia (AML), multiple myeloma (MM), cancer, high-throughput screening (HTS) ..more
_
   
 Tested Compounds
 Tested Compounds
All(25)
 
 
Active(24)
 
 
Inconclusive(1)
 
 
 Tested Substances
 Tested Substances
All(26)
 
 
Active(25)
 
 
Inconclusive(1)
 
 
AID: 588434
Data Source: Broad Institute (2063-06_Inhibitor_Dose_DryPowder_Activity_Set2)
BioAssay Type: Confirmatory, Concentration-Response Relationship Observed
Depositor Category: NIH Molecular Libraries Probe Production Network
Deposit Date: 2011-10-03

Data Table ( Complete ):           View Active Data    View All Data
Target
BioActive Compounds: 24
Related Experiments
AIDNameTypeComment
2709Summary of Broad Institute MLPCN Glycogen Synthase Kinase-3 alpha ProjectSummarydepositor-specified cross reference: Summary assay
2650Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alphaScreeningsame project related to Summary assay
463203Luminescence Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of GSK-3 alphaConfirmatorysame project related to Summary assay
463205Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-gloConfirmatorysame project related to Summary assay
588361Inhibition of Human GSK-3 alpha Activity Measured in Biochemical System Using Microfluidics - 2063-06_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
588406Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
588429Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2Confirmatorysame project related to Summary assay
588430Inhibition of Human CDK5 Activity Measured in Biochemical System Using Microfluidics - 2063-07_Inhibitor_Dose_DryPowder_ActivityConfirmatorysame project related to Summary assay
Description:
Keywords: Glycogen synthase kinase-3 alpha (GSK3alpha), kinase, acute myeloblastic leukemia (AML), multiple myeloma (MM), cancer, high-throughput screening (HTS)

Assay Overview:
GSK-3 alpha has emerged as a target for acute myeloblastic leukemia (AML) and multiple myeloma (MM) in both RNAi-based and chemical genomic-based high-throughput screening. The overall objective is to identify one or more specific inhibitors of GSK-3 alpha with micromolar potency. We had conducted a primary screen and identified active compounds inhibiting GSK3alpha activity. Now we measured the potency of these compounds under the following conditions: 3.2 nM of GSK-3 alpha (as a GST fusion from BPS Bioscience) was incubated with active compounds in doses in the presence of 4.3 uM of ATP (for specific reaction conditions see Protocol) for 60 minutes at ambient temperature in 384-well plates (Seahorse Bioscience, MA). The kinase activity was measured with EZ Reader II (Caliper Life Sciences, MA) as percent conversion. Positive control (GW8510 at 20 uM; CID 6539118) was included in each plate and used to scale the data in conjunction with in-plate DMSO controls (details see Data Analysis in Comments section).

Expected Outcome: Inhibitors of GSK-3 alpha activity will show as loss of signal.
Protocol
Protocol:1) Dispense 20 uL/well of CBPE (Combi, Thermo)
2) Pin 100 nL/well of compounds (Cybi Well, Cybio)
3) Dispense 10 uL/well of ATP (Combi, Thermo)
4) Incubate at room temperature for 60 minutes.
5) Dispense 10 uL/well of 80 mM EDTA (Combi, Thermo)
6) Store the plates at -20oC until they are read in Caliper EZ ReaderII (Caliper).
Solutions:
CBPE:
Hepes 7.5100mMBrij-350.003%Tween200.004%MgCl210mMDTT (1M)3.8mMPeptide 15 (Caliper)12.3uMGSK3a64.2nM
ATP:
Hepes 7.5100mMBrij-350.003%Tween200.004%MgCl210mMATP13.3uM
Comment
PRESENCE OF CONTROLS: Neutral control wells (NC; n=60) and positive control wells (PC; n=12) were included on every plate.
EXPECTED OUTCOME: Active compounds result in decreasing readout signal.
The compounds were assayed in multiple independent instances using an identical protocol; each instance is called a 'test'. For each test, the following analysis was applied:
ACTIVE CONCENTRATION LIMIT:
For each sample, the highest valid tested concentration (Max_Concentration) was determined and the active concentration limit (AC_limit) was set to equal (3)(Max_Concentration).
NORMALIZATION:
The raw signals of the plate wells were normalized using the 'Neutral Controls Minus Inhibitors' method in Genedata Assay Analyzer (v7.0.3):
The median raw signal of the intraplate neutral control wells was set to a normalized activity value of 0.
The median raw signal of the intraplate positive control wells was set to a normalized activity value of -100.
Experimental wells values were scaled to this range.
PATTERN CORRECTION: No plate pattern correction algorithm from Genedata Condoseo (v.7.0.3) was applied.
MEASUREMENT USED TO DETERMINE ACTIVE CONCENTRATION (AC): AC50
AC values were calculated using the curve fitting strategies in Genedata Screener Condoseo (7.0.3).
AC values were calculated up to the active concentration limit described for each sample.
pAC was set to equal -1*log10(AC)
PUBCHEM_ACTIVITY_OUTCOME:
Activity_Outcome = 1 (inactive) when:
a) compound shows activity but in a direction opposite to the expected outcome
in these cases, values describing curve fitting parameters (Sinf, S0, Hill Slope, log_AC50, log_AC50_SE) are set to null
b) curve fit is constant where activity is > -30% and < 30% at all tested concentrations, or
c) AC > AC_limit
Activity_Outcome = 2 (active) when:
AC <= AC_limit
Activity_Outcome = 3 (inconclusive) when:
a) Curve fitting strategy resulted in a constant fit with activity >= -70% but <= -30%, or
b) The fit was deemed not valid due to poor fit quality.
PUBCHEM_ACTIVITY_SCORE:
If PUBCHEM_ACTIVITY_OUTCOME = 1 (inactive) or 3 (inconclusive),
then PUBCHEM_ACTIVITY_SCORE = 0
If PUBCHEM_ACTIVITY_OUTCOME = 2 (active)
then PUBCHEM_ACTIVITY_SCORE = (10)(pAC)
Scores relate to AC in this manner:
120 = 1 pM
90 = 1 nM
60 = 1 uM
30 = 1 mM
0 = 1 M
When the active concentration (AC) is calculated to be greater than the highest valid tested concentration (Max_Concentration), the PUBCHEM_ACTIVITY_SCORE is calculated using Max_Concentration as the basis.
When the active concentration (AC) is calculated to be less than the lowest tested concentration, the PUBCHEM_ACTIVITY_SCORE is calculated using the lowest tested concentration as the basis.
DATA AGGREGATION:
Once the data for each test was processed, the test number was appended to all column headers in that test's data set. The individual test results were then aggregated as follows:
1. The final PUBCHEM_ACTIVITY_OUTCOME was set to:
a. '2' (active) when all test outcomes were '2' (active), or
b. '1' (inactive) when all test outcomes were '1' (inactive), or
c. '3' (inconclusive) when the test outcomes were mixed.
2. The final ACTIVE_CONCENTRATION (AC) was set as follows:
a. If the final PUBCHEM_ACTIVITY_OUTCOME = 2, AC was set as the mean of the constituent test active concentrations;
b. If the final PUBCHEM_ACTIVITY_OUTCOME = 1 or 3, AC was left empty.
3. The final PUBCHEM_ACTIVITY_SCORE was calculated based on the aggregated ACTIVE_CONCENTRATION, using the same logic described above for individual test scores.
Note:
The individual dose data point columns ('Activity_at_xxuM') reported here represent the median of valid (unmasked) replicate observations at each concentration. These values are the inputs to a curve fitting algorithm.
All other data columns represent values which are derived during the curve fitting algorithm; this may sometimes include automatic further masking of some replicate data points.
Occasionally this results in perceived inconsistencies: for example, between the derived 'Maximal_Activity' and the apparent most active data point.
Categorized Comment - additional comments and annotations
From ChEMBL:
Assay Type: Binding
Result Definitions
Show more
TIDNameDescriptionHistogramTypeUnit
OutcomeThe BioAssay activity outcomeOutcome
ScoreThe BioAssay activity ranking scoreInteger
1AC50_Qualifier'>','=', or '<'String
2AC50_uM*The concentration at which activity reaches 50% of the maximumFloatμM
3pAC50_MEqual to -1*log10(AC50)String
4ACTIVITY_OUTCOME_TEST1The PubChem Activity Outcome for the subset of data included in the indicated Test number.Integer
5ACTIVITY_SCORE_TEST1The PubChem Activity Score for the subset of data included in the indicated Test number.Integer
6ASSAYDATA_COMMENT_TEST1Comments relevant to the subset of data included in the indicated Test number.String
7AC50_Qualifier_TEST1'>','=', or '<'String
8AC50_uM_TEST1The concentration at which activity reaches 50% of the maximumFloatμM
9pAC50_M_TEST1Equal to -1*log10(AC50)String
10Hill_Slope_TEST1The slope at AC50Float
11S0_(%)_TEST1The fitted activity value at zero concentrationFloat%
12Sinf_(%)_TEST1The fitted activity value at infinite concentrationFloat%
13Num_Points_TEST1The number of data points used to generate the plotInteger
14Max_Activity_(%)_TEST1The maximum activity value observed, based on mean of replicates per concentrationFloat%
15Max_Activity_Conc_uM_TEST1The concentration at which the maximum activity is observedFloatμM
16Max_Concentration_uM_TEST1Maximum valid test concentrationFloatμM
17Activity_at_0.01uM_(%)_TEST1 (0.01μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
18Activity_at_0.016uM_(%)_TEST1 (0.016μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
19Activity_at_0.0195uM_(%)_TEST1 (0.0195μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
20Activity_at_0.03uM_(%)_TEST1 (0.03μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
21Activity_at_0.035uM_(%)_TEST1 (0.035μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
22Activity_at_0.038uM_(%)_TEST1 (0.038μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
23Activity_at_0.068uM_(%)_TEST1 (0.068μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
24Activity_at_0.08uM_(%)_TEST1 (0.08μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
25Activity_at_0.135uM_(%)_TEST1 (0.135μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
26Activity_at_0.16uM_(%)_TEST1 (0.16μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
27Activity_at_0.26uM_(%)_TEST1 (0.26μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
28Activity_at_0.5uM_(%)_TEST1 (0.5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
29Activity_at_0.6uM_(%)_TEST1 (0.6μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
30Activity_at_1uM_(%)_TEST1 (1μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
31Activity_at_1.1uM_(%)_TEST1 (1.1μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
32Activity_at_1.2uM_(%)_TEST1 (1.2μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
33Activity_at_2.1uM_(%)_TEST1 (2.1μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
34Activity_at_2.6uM_(%)_TEST1 (2.6μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
35Activity_at_4.2uM_(%)_TEST1 (4.2μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
36Activity_at_5uM_(%)_TEST1 (5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
37Activity_at_8uM_(%)_TEST1 (8μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
38Activity_at_10uM_(%)_TEST1 (10μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
39Activity_at_16uM_(%)_TEST1 (16μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
40Activity_at_19.5uM_(%)_TEST1 (19.5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
41Activity_at_35uM_(%)_TEST1 (35μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
42ACTIVITY_OUTCOME_TEST2The PubChem Activity Outcome for the subset of data included in the indicated Test number.Integer
43ACTIVITY_SCORE_TEST2The PubChem Activity Score for the subset of data included in the indicated Test number.Integer
44ASSAYDATA_COMMENT_TEST2Comments relevant to the subset of data included in the indicated Test number.String
45AC50_Qualifier_TEST2'>','=', or '<'String
46AC50_uM_TEST2The concentration at which activity reaches 50% of the maximumFloatμM
47pAC50_M_TEST2Equal to -1*log10(AC50)String
48Hill_Slope_TEST2The slope at AC50Float
49S0_(%)_TEST2The fitted activity value at zero concentrationFloat%
50Sinf_(%)_TEST2The fitted activity value at infinite concentrationFloat%
51Num_Points_TEST2The number of data points used to generate the plotInteger
52Max_Activity_(%)_TEST2The maximum activity value observed, based on mean of replicates per concentrationFloat%
53Max_Activity_Conc_uM_TEST2The concentration at which the maximum activity is observedFloatμM
54Max_Concentration_uM_TEST2Maximum valid test concentrationFloatμM
55Activity_at_0.01uM_(%)_TEST2 (0.01μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
56Activity_at_0.016uM_(%)_TEST2 (0.016μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
57Activity_at_0.0195uM_(%)_TEST2 (0.0195μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
58Activity_at_0.03uM_(%)_TEST2 (0.03μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
59Activity_at_0.035uM_(%)_TEST2 (0.035μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
60Activity_at_0.038uM_(%)_TEST2 (0.038μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
61Activity_at_0.068uM_(%)_TEST2 (0.068μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
62Activity_at_0.08uM_(%)_TEST2 (0.08μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
63Activity_at_0.135uM_(%)_TEST2 (0.135μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
64Activity_at_0.16uM_(%)_TEST2 (0.16μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
65Activity_at_0.26uM_(%)_TEST2 (0.26μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
66Activity_at_0.3uM_(%)_TEST2 (0.3μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
67Activity_at_0.5uM_(%)_TEST2 (0.5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
68Activity_at_0.6uM_(%)_TEST2 (0.6μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
69Activity_at_1uM_(%)_TEST2 (1μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
70Activity_at_1.1uM_(%)_TEST2 (1.1μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
71Activity_at_1.2uM_(%)_TEST2 (1.2μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
72Activity_at_2.1uM_(%)_TEST2 (2.1μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
73Activity_at_2.6uM_(%)_TEST2 (2.6μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
74Activity_at_4.2uM_(%)_TEST2 (4.2μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
75Activity_at_5uM_(%)_TEST2 (5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
76Activity_at_8uM_(%)_TEST2 (8μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
77Activity_at_10uM_(%)_TEST2 (10μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
78Activity_at_16uM_(%)_TEST2 (16μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
79Activity_at_19.5uM_(%)_TEST2 (19.5μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%
80Activity_at_35uM_(%)_TEST2 (35μM**)The average measured activity of all accepted replicates at the specified concentrationFloat%

* Activity Concentration. ** Test Concentration.
Additional Information
Grant Number: 1 R03 MH087442-01

Data Table (Concise)
Data Table ( Complete ):     View Active Data    View All Data
Classification
PageFrom: